KELLY VAZQUEZ: Open Payments
NPI 1215385380 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,734 in 187 payments from 26 companies in 2025. Trend: 2023 $1,994 · 2024 $3,245 · 2025 $4,734
Food & beverage: $4,699Education: $35
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 35 | $729 |
| GENZYME CORPORATION | 18 | $421 |
| Pulmonx Corporation | 3 | $364 |
| Regeneron Healthcare Solutions, Inc. | 13 | $347 |
| AstraZeneca Pharmaceuticals LP | 8 | $331 |
| GlaxoSmithKline, LLC. | 14 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $205 |
| Inspire Medical Systems, Inc. | 3 | $203 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $197 |
| Grifols USA, LLC | 7 | $191 |
Products named: DUPIXENT, Arikayce, CHARTIS CATHETER, AIRSUPRA, INSPIRE, LUMRYZ, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
